Joint Rome Declaration: Together for Access to Medicines

Back to the "Endorsements and Sign-ons" list

EATG and other members of the European Alliance for Responsible R&D and Affordable Medicines have joined their voices in the Joint Rome Declaration to raise awareness and concerns on the most pressing issues related to access to affordable medicines, including the EU’s Pharmaceutical Strategy

The members of the European Alliance for Responsible R&D and Affordable Medicines have joined their voices in the Joint Rome Declaration to raise awareness and concerns on the most pressing issues related to access to affordable medicines, including the EU’s Pharmaceutical Strategy.


The COVID-19 outbreak has shown that the quest for equitable access to medicines facilitated by a fairer biomedical R&D system still remain work in progress. It is time for global, European and national legislators to bring balance to the current system of pharmaceutical incentives so that it serves the public interest via a patient-centered approach. to:

  1. Secure available, affordable and accessible medicines
  2. Use incentives for new antibiotics that delink the cost of investment in R&D from the prices and volume of sales
  3. Set higher standards for patentability at the European Patent Office
  4. Remove legislative and regulatory obstacles to the use of TRIPS flexibilities
  5. Promote transparency of R&D and other costs as well as net prices of medicines
  6. Adopt laws, regulations and public funding conditionalities that ensure that the results of all clinical trials are made public
  7. Ensure transparency and accountability of political decision at EMA and HERA
  8. Commit public funds to support a needs-driven approach to pharmaceutical R&D and address unmet needs
  9. Prevent medicine shortages and reduce their impact on patients and healthcare providers
  10. Ensure the co-creation of European pharmaceutical policies by facilitating the meaningful involvement of patients, consumers, and healthcare professionals and civil society
  11. Strengthen existing legislation on the human rights duties of pharmaceutical companies in relation to access to medicines in the EU


We are confident that policymakers will prioritise health to enable real learning from recent crises.

Shall you have any inquiries, please don’t hesitate to contact Alba Gil (), Junior Policy Manager for Healthcare Delivery at the European Public Health Alliance (EPHA)


Endorsing Organisations

  1. Acceso Justo al Medicamento
  2. Access to Medicines Ireland
  3. Action against AIDS Germany
  4. AIDES
  5. AIDS Action Europe
  6. ARAS – Romanian Association Against AIDS
  7. BUKO Pharma-Kampagne
  9. European AIDS Treatment Group
  10. European Public Health Alliance (EPHA)
  11. France Assos Santé
  12. Global Health Advocates
  13. Health Action International (HAI)
  14. Just Treatment
  15. Médecins du Monde International Network
  16. Oxfam
  17. Pharmaceutical Accountability Foundation
  18. Prescrire
  19. Public Eye
  20. Salud por Derecho
  21. SOMO
  22. UAEM Europe
  23. Wemos

Get involved

Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?


Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.